Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Clinical trial NCT01522443 · TERMINATED

Trial details

NCT number: NCT01522443
Sponsor: Exelixis
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer Castration Resistant Prostate Cancer Pain Prostatic Neoplasms

Start date: 2012-03-01
Primary completion: 2014-10-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.